SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-03-034225
Filing Date
2003-08-12
Accepted
2003-08-12 15:24:41
Documents
5
Period of Report
2003-06-28

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 373042
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 dex311.htm EX-31.1 9726
4 CERTIFICATION PURSUANT TO CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 dex312.htm EX-31.2 9718
5 CERTIFICATION OF PRINCIPLE EXECUTIVE OFFICER dex321.htm EX-32.1 4064
6 CERTIFICATION OF THE PRINCIPLE FINANCIAL OFFICER dex322.htm EX-32.2 4082
  Complete submission text file 0001193125-03-034225.txt   402820
Mailing Address 100 BEAVER STREET WALTHAM MA 02453
Business Address 1OO BEAVER ST WALTHAM MA 02453 7813982300
GENOME THERAPEUTICS CORP (Filer) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-10824 | Film No.: 03837459
SIC: 2835 In Vitro & In Vivo Diagnostic Substances